CFDA-话题@MedSci

#CFDA#

184篇内容 | 3714人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890660, encodeId=e3b6189066092, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=【CFDA直播解读】建国后最重大的行业政策改革！利好谁？, objectType=article, longId=115482, objectId=edbf11548255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edbf11548255, replyNumber=0, likeNumber=58, createdTime=2018-01-30, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edbf11548255, moduleTitle=【CFDA直播解读】建国后最重大的行业政策改革！利好谁？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edbf11548255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890634, encodeId=628f1890634d4, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA仿制药一致性评价有调整！, objectType=article, longId=101439, objectId=b5e1101439cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5e1101439cf, replyNumber=0, likeNumber=56, createdTime=2018-05-11, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5e1101439cf, moduleTitle=CFDA仿制药一致性评价有调整！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5e1101439cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890704, encodeId=cf741890e0487, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA公告四产品修改说明有产品被禁网售, objectType=article, longId=129098, objectId=07c11290980c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07c11290980c, replyNumber=0, likeNumber=79, createdTime=2018-03-09, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07c11290980c, moduleTitle=CFDA公告四产品修改说明有产品被禁网售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07c11290980c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890677, encodeId=1f4918906e731, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA批准上市Giotrif®（阿法替尼），单药治疗EGFR敏感突变的晚期非小细胞肺癌, objectType=article, longId=121901, objectId=1fe812190145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe812190145, replyNumber=0, likeNumber=70, createdTime=2018-10-05, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe812190145, moduleTitle=CFDA批准上市Giotrif®（阿法替尼），单药治疗EGFR敏感突变的晚期非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe812190145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890700, encodeId=42e81890e00e1, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=加大药品标准淘汰力度！CFDA发布加强食品药品标准工作指导意见, objectType=article, longId=127112, objectId=2ec712e11231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ec712e11231, replyNumber=0, likeNumber=66, createdTime=2018-12-21, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ec712e11231, moduleTitle=加大药品标准淘汰力度！CFDA发布加强食品药品标准工作指导意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ec712e11231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890659, encodeId=4ea7189065917, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：16批次药品抽检不合格, objectType=article, longId=114801, objectId=0e94114801e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e94114801e9, replyNumber=0, likeNumber=65, createdTime=2018-08-12, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e94114801e9, moduleTitle=CFDA：16批次药品抽检不合格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e94114801e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890649, encodeId=a85b189064966, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA发布《药品境外检查规定》意见稿强化进口药品监管, objectType=article, longId=111685, objectId=3fa8111685c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fa8111685c4, replyNumber=0, likeNumber=69, createdTime=2018-02-17, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fa8111685c4, moduleTitle=CFDA发布《药品境外检查规定》意见稿强化进口药品监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fa8111685c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890674, encodeId=350e18906e4b0, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA批准上市洛珊®（布南色林片）审评概述, objectType=article, longId=121791, objectId=97d3121e9121, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97d3121e9121, replyNumber=0, likeNumber=69, createdTime=2018-06-06, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97d3121e9121, moduleTitle=CFDA批准上市洛珊®（布南色林片）审评概述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97d3121e9121)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890669, encodeId=bdc218906694b, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA禁止网售处方药动了谁的奶酪？, objectType=article, longId=120242, objectId=f921120242b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f921120242b3, replyNumber=0, likeNumber=69, createdTime=2017-11-30, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f921120242b3, moduleTitle=CFDA禁止网售处方药动了谁的奶酪？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f921120242b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890612, encodeId=8d6918906123c, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=注意了！CFDA通告保胎灵等15批次药品不合格, objectType=article, longId=89521, objectId=4c2589521de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c2589521de, replyNumber=0, likeNumber=73, createdTime=2017-04-05, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c2589521de, moduleTitle=注意了！CFDA通告保胎灵等15批次药品不合格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c2589521de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890673, encodeId=07ec18906e348, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：中成药名禁用宝灵精公众普遍接受者可不改名, objectType=article, longId=121788, objectId=960e121e882c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=960e121e882c, replyNumber=0, likeNumber=74, createdTime=2018-05-01, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=960e121e882c, moduleTitle=CFDA：中成药名禁用宝灵精公众普遍接受者可不改名, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=960e121e882c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890633, encodeId=891d18906330d, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=祝贺CFDA！ICH成员国，中国加入正当时！, objectType=article, longId=100532, objectId=c852100532e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c852100532e3, replyNumber=0, likeNumber=64, createdTime=2017-07-24, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c852100532e3, moduleTitle=祝贺CFDA！ICH成员国，中国加入正当时！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c852100532e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890638, encodeId=f3da189063819, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA拟放宽II、III类注册检验要求，企业可以自主检验, objectType=article, longId=103999, objectId=07931039990a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07931039990a, replyNumber=0, likeNumber=57, createdTime=2017-12-04, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07931039990a, moduleTitle=CFDA拟放宽II、III类注册检验要求，企业可以自主检验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07931039990a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890632, encodeId=6d79189063204, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=DIA2017丨CFDA专场：监管改革推动药品质量和创新, objectType=article, longId=99653, objectId=7b76996535d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b76996535d, replyNumber=0, likeNumber=61, createdTime=2017-10-23, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b76996535d, moduleTitle=DIA2017丨CFDA专场：监管改革推动药品质量和创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b76996535d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890693, encodeId=60b318906936a, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：什么是移动医疗器械？, objectType=article, longId=125308, objectId=367b125308be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=367b125308be, replyNumber=0, likeNumber=80, createdTime=2018-10-04, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=367b125308be, moduleTitle=CFDA：什么是移动医疗器械？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=367b125308be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890689, encodeId=701c18906894b, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA发文：近90%的中成药需改说明书！, objectType=article, longId=125024, objectId=a649125024bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a649125024bc, replyNumber=0, likeNumber=87, createdTime=2018-09-28, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a649125024bc, moduleTitle=CFDA发文：近90%的中成药需改说明书！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a649125024bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890641, encodeId=17261890641b3, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA开查医械临床试验数据造假, objectType=article, longId=105306, objectId=d7d4105306f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d4105306f3, replyNumber=0, likeNumber=67, createdTime=2017-10-17, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d4105306f3, moduleTitle=CFDA开查医械临床试验数据造假, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d4105306f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890619, encodeId=2e7e18906193f, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA关于修订烟酸类调脂药品说明书的公告, objectType=article, longId=93442, objectId=86189344280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86189344280, replyNumber=0, likeNumber=74, createdTime=2017-06-27, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86189344280, moduleTitle=CFDA关于修订烟酸类调脂药品说明书的公告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86189344280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890675, encodeId=5c0218906e580, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA批准上市雅美罗®（托珠单抗注射液），用于治疗全身型幼年特发性关节炎, objectType=article, longId=121792, objectId=c46f121e9221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c46f121e9221, replyNumber=0, likeNumber=138, createdTime=2018-03-26, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c46f121e9221, moduleTitle=CFDA批准上市雅美罗®（托珠单抗注射液），用于治疗全身型幼年特发性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c46f121e9221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890620, encodeId=bb271890620bf, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=肺癌重磅消息！阿斯利康第三代靶向肺癌药物Tagrisso获中国CFDA批准, objectType=article, longId=94068, objectId=ee9c9406868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee9c9406868, replyNumber=0, likeNumber=52, createdTime=2017-06-22, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee9c9406868, moduleTitle=肺癌重磅消息！阿斯利康第三代靶向肺癌药物Tagrisso获中国CFDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee9c9406868)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CFDA

2020-05-29

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

【CFDA直播解读】建国后最重大的行业政策改革！利好谁？

2018-01-30

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA仿制药一致性评价有调整！

2018-05-11

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA公告四产品修改说明有产品被禁网售

2018-03-09

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA批准上市Giotrif®（阿法替尼），单药治疗EGFR敏感突变的晚期非小细胞肺癌

2018-10-05

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

加大药品标准淘汰力度！CFDA发布加强食品药品标准工作指导意见

2018-12-21

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：16批次药品抽检不合格

2018-08-12

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA发布《药品境外检查规定》意见稿强化进口药品监管

2018-02-17

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA批准上市洛珊®（布南色林片）审评概述

2018-06-06

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA禁止网售处方药动了谁的奶酪？

2017-11-30

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

注意了！CFDA通告保胎灵等15批次药品不合格

2017-04-05

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：中成药名禁用宝灵精公众普遍接受者可不改名

2018-05-01

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

祝贺CFDA！ICH成员国，中国加入正当时！

2017-07-24

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA拟放宽II、III类注册检验要求，企业可以自主检验

2017-12-04

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

DIA2017丨CFDA专场：监管改革推动药品质量和创新

2017-10-23

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：什么是移动医疗器械？

2018-10-04

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA发文：近90%的中成药需改说明书！

2018-09-28

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA开查医械临床试验数据造假

2017-10-17

docwu2019 (审核中...)

前往app查看评论内容

#CFDA#

CFDA关于修订烟酸类调脂药品说明书的公告

2017-06-27

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA批准上市雅美罗®（托珠单抗注射液），用于治疗全身型幼年特发性关节炎

2018-03-26

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

肺癌重磅消息！阿斯利康第三代靶向肺癌药物Tagrisso获中国CFDA批准

2017-06-22

科室
- - 订阅+
  - 更多科室
工具
服务